The investigation specifically targets potential conflicts of interest within the boardroom of the NYSE-listed company. Kuehn Law is currently soliciting input from long-term stockholders to determine if the conduct of executives has compromised shareholder value. According to the firm, those who hold stock in RCUS may be eligible for legal remedies if a breach of duty is established.
In section Releases
Kuehn Law Launches Probe Into Arcus Biosciences Governance
Shareholders of Arcus Biosciences, Inc. now face a potential legal inquiry as New York-based Kuehn Law, PLLC investigates allegations of self-dealing among the company’s leadership. The firm is examining whether officers and directors breached their fiduciary duties, potentially opening the door for litigation aimed at corporate governance reforms.
Investors interested in the proceedings are directed to contact Sophia Anne Silayan. The law firm has stated that it covers all case costs for clients, operating on a no-obligation consultation basis. With legal rights often subject to strict filing deadlines, the firm is urging stakeholders to act promptly to address concerns regarding the company’s internal management and market transparency.
Comments (0)
No comments yet. Be the first!